In 1999, the European Union (EU) approved 3 rapid methods for the testing of bovine brain samples for the presence of bovine spongiform encephalopathy (BSE). The evaluation that led to the approval did not include an analysis of autolyzed material. Member states of the EU have active surveillance programs for BSE, which target fallen stock as well as other categories of cattle. Autolysis is a common feature of fallen stock samples because there can be a considerable delay between death and collection of samples. Therefore, it is important to know whether these tests perform optimally on autolyzed samples. The Veterinary Laboratories Agency (VLA) selected 250 positive fallen stock samples. These had been detected during routine testing using the Prionics-Check Western blot and confirmed as BSE cases by immunohistochemistry or electron microscopy. Samples were graded according to the degree of autolysis and then tested by the 3 methods: Prionics-Check Western blot, Platelia test, and Enfer test. All 3 methods correctly classified the samples as positive BSE cases, therefore alleviating doubt about their ability to do so. Subsequent EU validation exercises, such as those conducted in 2002-2003, have included the testing of autolyzed material. It is important that all new methods be evaluated on autolyzed tissue before approval for official use.
Introduction
The bovine spongiform encephalopathy (BSE) epidemic in Great Britain and the emergence in humans of a new variant Creutzfeld-Jakob disease of a probable dietary origin have increased awareness of transmissible spongiform encephalopathies (TSEs). Many control measures have been introduced in the European Union (EU) to reduce the risk of transmission of BSE to humans and ruminants. For example, the use of specified risk materials in human food has been banned, as has the use of meat and bonemeal in livestock feed. Active surveillance for BSE was introduced in 2001 to determine more precisely the scale of the European epidemic. The surveillance program involves the testing of brain tissue from certain categories of cattle slaughtered for human consumption, including casualties and fallen stock more than 24 months of age. Casualties and fallen stock are generally referred to as ''risk animals'' because of the recognition that, with the exception of cattle suffering from clinical BSE, they represent the subpopulation of national herds that has the highest incidence of BSE detected by active testing. 3 Approved tests rely on the detection of abnormal prion protein (PrP sc ). Cellular prion protein (PrP c ) is a normal component of many cells, although its function is not known. It is widely accepted that a conformational change in PrP c to give an increase in the ␤pleated sheet-␣-helix ratio 7 results in the formation of PrP sc . The presence of this abnormally folded form of the protein is associated with the onset of disease in BSE and other prion diseases. 2 A number of immunoassays that exploit these changes in structure and consequential partial resistance to enzymatic digestion have been developed to provide ''rapid'' (compared with conventional techniques such as histology) detection of PrP sc in central nervous system tissue.
After an evaluation by the European Commission in 1999 (http://europa.eu.int/comm/food/fs/bse/bse12en. html), 6 3 rapid tests, the Enfer test, a the Platelia test, b and the Prionics-Check Western blot, c were approved for use as surveillance tools in the EU. A positive result suggests that the animal has BSE; this may be confirmed by reference methods such as histopathology, immunohistochemistry (IHC), electron microscopy, or OIE Western blot. For the evaluation process, the status of positive and negative brain samples was initially established by histopathological examination of brain stems at the level of the obex. Positive brain samples were all derived from clinically affected BSE cases in the UK. Negative samples came from healthy cattle from New Zealand. The samples were all in good condition, and none were autolyzed.
Although the majority of samples tested in surveillance programs are collected in good condition from freshly slaughtered animals, a proportion, especially from fallen stock, are autolyzed. With the exception of limited studies on the effect of autolysis on the effectiveness of the Prionics-Check Western blot, 1, 5, 8 there is no published data on the effects of autolysis on the performance of the other tests used. Schaller et al. 8 reported on the use of the Prionics-Check Western blot for surveillance of BSE, correctly detecting 2 completely autolyzed and several partially autolyzed samples, suggesting that PrP sc survives autolysis. Chaplin et al. 1 performed controlled autolysis on brain stem samples from 12 BSE-affected cattle and 17 scrapie-affected sheep. Of the confirmed BSE samples, PrP sc could be detected in the medulla (and several other areas) by IHC after 7 days at 37 C. The scrapie samples were also positive after 7 days at 37 C, although variability in PrP sc concentration within the brain stem highlighted its potential to confound evaluation of test performance on single samples. The use of artificial methods to induce autolysis is a useful starting point but raises questions regarding the bacterial flora present and how accurately the system re-flects field conditions. The aim of this study was to compare the sensitivity of 3 EU approved rapid test methods on naturally autolyzed bovine brain material.
Materials and methods
Samples. Samples of brain stem (medulla caudal to the obex) were tested in 2001 and 2002 as part of the routine surveillance program on British fallen stock and casualty animals more than 30 mo of age (now reduced to 24 mo). Positive samples detected by Prionics-Check Western blot were stored at Ϫ70 C and confirmed using IHC 4 at the UK National Reference Laboratory for TSEs. A total of 250 confirmed positive samples were available for this study.
Protocol. The samples were removed from Ϫ70 C storage, and when thawed, the degree of autolysis was assessed and scored using a ranking system from 1 to 6. The scoring system is shown in Table 1 . Samples were dissected to yield 4 pieces, with weight appropriate to each test plus a spare (0.5 g for Prionics-Check Western blot, 0.35 g for Platelia, 0.5 g for Enfer, 0.5 g for spare sample). Samples were assigned randomly from the approximate areas of brain stem shown in Fig. 1 . Positive site identification was not possible with more autolyzed tissues (rank number 5 and 6). In such cases, all 4 samples were selected from the same tissue mass.
Samples were tested using the Enfer a test, the Platelia b test, or the Prionics-Check Western blot c according to the manufacturers' instructions. All Enfer tests were performed by the Laboratory of the Government Chemist (LGC, Teddington) in the UK. Samples giving discrepant results were either repeated or sent to external laboratories for verification. Samples requiring additional Platelia tests were sent to the German National Reference Laboratory.
Statistical analysis. The 95% confidence limits for sensitivity were determined using STATA 9 software to solve the equation 0.05 ϭ P n , where n is the number of samples tested and P is the calculated probability.
Results
The results of the assays are shown in Table 2 . Final results showed that each of the tests classified all the samples tested as positive. Figure 2 illustrates the distribution of samples according to state of autolysis. Because the 3 rapid tests in this study are not meant to be used for quantitative analysis, no comparison of optical density, signal intensity, or light unit readings was made against the relative level of autolysis observed in the samples. Discrepant results (defined according to assignment to diagnostic category) never occurred in the same tissue for more than 1 test and are listed in Table 1 , according to autolysis categories. The 1-sided 95% confidence intervals for sensitivity are shown in Table 2 . When n ϭ 250, P ϭ 0.9881. When n ϭ 248, P ϭ 0.9880. Because 100% positives were recorded, the upper tail of the confidence interval has vanished, and therefore, the entire 5% probability is put into the lower tail. This can be interpreted as: if true sensitivity is 98.81%, then there is a 5% chance of recording no negatives in 250 tests.
Discussion
The EU countries are able to use whichever approved rapid tests they wish for TSE screening, according to Annex X of EU Regulation 999/2001. Different types of cattle are tested. These can be divided into risk animals (fallen stock, casualties, and BSE suspects) and healthy animals going into the food chain. All cattle more than 30 months of age slaughtered for human consumption and all fallen stock or casualties more than 24 months of age (previously more than 30 months) must now be tested. In the UK, because of the presence of the Over Thirty Months (OTM) scheme, only targeted populations of healthy OTM-slaughtered cattle are tested. Rapid testing of ab-attoir samples usually involves testing good-quality material collected rapidly postmortem, and few of this type of samples are autolyzed. However, autolysis is a common feature of samples collected from fallen stock.
Results, prevalence estimates, and the evaluation of the effectiveness of control measures could be influenced, if performance of any of the tests was compromised by autolyzed samples. The potential effect of autolysis can be divided into 2 separate components: 1) whether the test is compromised by the state of the sample per se, and 2) whether an appropriate sample can be identified when tissue morphology has degenerated in autolyzed material. The results obtained in this study suggest that the 3 EU-approved BSE rapid tests assessed in this study are all able to detect PrP sc in autolyzed tissue. The samples used in the study were selected initially as positive from routine screening of fallen stock animals, using the Prionics-Check Western blot. This means that the performance of the other 2 tests can only be compared with this baseline. Further work could apply other rapid or confirmatory tests for the initial selection of autolyzed positive samples.
These results improve the quality of the validation data available for TSE rapid tests and show that the tests perform in a robust manner when testing autolyzed samples. Rapid tests are used for screening purposes, and it is important that they should identify positive samples in autolyzed tissue as effectively as in ''normal'' brain stem material. If they do not, false negative results would ensue, which means that TSEinfected animals would be reported as negative.
The aim of this study was not to compare the analytical sensitivity of the 3 tests. It is not possible to comment upon the comparative sensitivity of the methods, apart from saying that the Enfer and Platelia tests appear to be as sensitive as the Prionics-Check Western blot for the detection of PrP sc in autolyzed samples. Data on the use of the Prionics-Check Western blot on autolyzed material has been reported previously. The test has been used extensively in Switzerland to assess samples from a range of carcasses, including fallen stock. 1 When autolysis was induced by storing samples under controlled conditions, the Prionics-Check West-ern blot was able to detect positive BSE and scrapie samples after storage for 7 days at 37 C. 1 Since this study was completed, 2 further tests have been approved by the EU for BSE surveillance purposes. These are the Conformational Dependent Immunoassay (CDI) d and the Prionics Luminescent Immunoassay (LIA) c tests. These tests were approved by the EU in 2003 (http://europa.eu.int/comm/food/fs/bse/ bse42en.pdf) and (http://europa.eu.int/comm/food/fs/ sc/ssc/out316en.pdf). The 2002 EU evaluation of the CDI and Prionics LIA tests that led to approval included a field trial component, which involved the testing of poor-quality samples. Both tests were able to categorize poor-quality material accurately.
